Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06476600Completed
Randomised, double-blind trial of dexmedetomidine (2 arms). Primary endpoint: Quality of Recovery-15 Score. Started Jul 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06476600.